CB46975-22 - 0x0000000000006A25

Healthy Males & Females

Refresh

* Stipend may pay up to reflected amount.
Start Date: 
April 11, 2026 - 2:30pm
End Date: 
May 10, 2026 - 9:00am

Study Details

Study Number: CB46975
Group Number: 22
Study Requirement: Healthy Normal Male and Female
Stipend: up to $12,750.00

Study Criteria

Age: 19 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat atopic dermatitis.
Route of Administration: Oral
Blood Draws: 37

Study Schedule

Schedule Type: Long Term
Study Length: 22 - Night Stay & 1 Return

Screening Dates:

Event Day Event Date
Thursday 4/2/2026
Friday 4/3/2026
Thursday 4/9/2026
Friday 4/10/2026

Doctor Exam Dates:

Event Day Event Date
Thursday 4/2/2026
Friday 4/3/2026
Thursday 4/9/2026
Friday 4/10/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Saturday 4/11/2026 2:30:00 PM Sunday 5/3/2026 9:30:00 AM 1 Lincoln
Return Sunday 5/10/2026 8:00:00 AM Sunday 5/10/2026 9:00:00 AM 1 Lincoln